Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Contextlogic Inc Cl A (LOGC)

Contextlogic Inc Cl A (LOGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 139,069
  • Shares Outstanding, K 24,398
  • Annual Sales, $ 5,410 K
  • Annual Income, $ -40,030 K
  • 60-Month Beta 2.09
  • Price/Sales 0.47
  • Price/Cash Flow N/A
  • Price/Book 0.83
Trade LOGC with:

Options Overview Details

View History
  • Implied Volatility 43.98% ( -1.84%)
  • Historical Volatility 62.28%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 69.99% on 05/14/24
  • IV Low 43.98% on 05/16/24
  • Put/Call Vol Ratio 0.11
  • Today's Volume 136
  • Volume Avg (30-Day) 967
  • Put/Call OI Ratio 0.24
  • Today's Open Interest 47,133
  • Open Int (30-Day) 35,087

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.87 +13.55%
on 04/18/24
6.12 -9.64%
on 04/23/24
+0.47 (+9.29%)
since 04/16/24
3-Month
4.68 +18.04%
on 04/16/24
6.95 -20.43%
on 02/20/24
-1.32 (-19.27%)
since 02/16/24
52-Week
3.55 +55.70%
on 10/30/23
9.90 -44.14%
on 08/01/23
-2.29 (-29.28%)
since 05/16/23

Most Recent Stories

More News
Alexion, AstraZeneca Rare Disease, Completes Acquisition of LogicBio® Therapeutics

Alexion, AstraZeneca Rare Disease, today announced the completion of its acquisition of LogicBio® Therapeutics, Inc. (NASDAQ: LOGC), a pioneering genomic medicine company.

AZN : 77.04 (+0.09%)
LOGC : 5.53 (-2.98%)
LogicBio Therapeutics: Q3 Earnings Snapshot

LogicBio Therapeutics: Q3 Earnings Snapshot

LOGC : 5.53 (-2.98%)
LogicBio Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates

/PRNewswire/ -- LogicBio® Therapeutics, Inc. (NASDAQ: LOGC), a clinical-stage genetic medicine company, today reported financial results for the third quarter...

LOGC : 5.53 (-2.98%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BTRS, JVA, AKUS, LOGC

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

BTRS : 9.49 (-0.11%)
JVA : 1.4663 (+3.26%)
AKUS : 13.29 (+1.06%)
LOGC : 5.53 (-2.98%)
SHAREHOLDER ALERT: Weiss Law Reminds LOGC, POSH, AERC, and BTRS Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

LOGC : 5.53 (-2.98%)
POSH : 17.90 (unch)
AERC : 3.40 (+0.59%)
BTRS : 9.49 (-0.11%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AAWW, LOGC, RFP, PBFX, RNWK

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

AAWW : 102.48 (+0.02%)
LOGC : 5.53 (-2.98%)
RFP : 21.92 (-0.36%)
PBFX : 19.90 (-2.40%)
RNWK : 0.7300 (+0.03%)
LOGICBIO® THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of LogicBio® Therapeutics, Inc. - LOGC

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of LogicBio® Therapeutics, Inc. (NasdaqGM: LOGC)...

LOGC : 5.53 (-2.98%)
SHAREHOLDER ALERT: Weiss Law Reminds LOGC, POSH, AERC, and BTRS Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

LOGC : 5.53 (-2.98%)
POSH : 17.90 (unch)
AERC : 3.40 (+0.59%)
BTRS : 9.49 (-0.11%)
Central Nervous System Disorders Therapeutics Market Expected to Reach $159 Billion by 2028

Palm Beach, FL –– October 12, 2022 – FinancialNewsMedia.com News Commentary – The COVID pandemic has not only had a negative effect on most markets but it has also spurred growth in several worldwide...

KTTA : 6.50 (-2.26%)
AZN : 77.04 (+0.09%)
LOGC : 5.53 (-2.98%)
CRDF : 3.74 (+4.76%)
SWTX : 44.77 (-0.95%)
DAWN : 16.03 (-2.38%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LOTZ, LOGC, OIIM, JVA

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

LOTZ : 0.1480 (-1.99%)
LOGC : 5.53 (-2.98%)
OIIM : 4.90 (unch)
JVA : 1.4663 (+3.26%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar